Three months after President Biden signed an executive order to accelerate biotechnology innovation, the administration formally asked stakeholders and the public on Monday to identify gaps, ambiguities and inefficiencies in federal regulation of the sector. The FDA, EPA and USDA share jurisdiction over biotechnology. In a notice scheduled to appear in the Federal Register on… » Read More
The Ag Insider content is only available to members.